Gen AI can create diverse content and data formats, revolutionizing the AI landscape and transforming businesses. The pharmaceutical industry can use gen AI to sift through vast clinical data volumes, enabling trial protocols’ drafting and improving clinical trial success rates.

In this viewpoint, we present Everest Group’s findings from a survey of 50 pharmaceutical enterprises to evaluate their gen AI expectations, its adoption patterns, and insights into the technology’s role in clinical development. The report offers detailed insights into gen AI’s applications, potential impact, adoption challenges, and best practices to achieve a strategic advantage in the dynamic technology landscape.

Pharmaceutical companies can use this report to gain valuable peer perspectives on gen AI, identify essential functionalities when choosing tools/platforms, and understand gen AI’s role in achieving business objectives.

Scope

• Industry: pharmaceutical
• Geography: global

Contents

In this report, we:

• Assess pharmaceutical enterprises’ gen AI objectives
• Evaluate investment strategies and procurement initiatives to implement gen AI solutions
• Identify gen AI’s adoption challenges
• Recommend an enterprise framework to adopt and scale gen AI initiatives

Membership(s)

Life Sciences Information Technology

Sourcing and Vendor Management